Kura Oncology Company Profile (NASDAQ:KURO)

About Kura Oncology (NASDAQ:KURO)

Kura Oncology logo

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:KURO
  • CUSIP: N/A
  • Web: N/A
Capitalization:
  • Market Cap: $174.1 million
  • Outstanding Shares: 14,508,000
Average Prices:
  • 50 Day Moving Avg: $12.00
  • 200 Day Moving Avg: $12.00
  • 52 Week Range: $12.00 - $12.00
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.80
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: $4.08 per share
  • Price / Book: 2.94
Profitability:
  • EBIDTA: ($11,800,000.00)
 
Frequently Asked Questions for Kura Oncology (NASDAQ:KURO)

What is Kura Oncology's stock symbol?

Kura Oncology trades on the NASDAQ under the ticker symbol "KURO."

Who are some of Kura Oncology's key competitors?

How do I buy Kura Oncology stock?

Shares of Kura Oncology can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Kura Oncology's stock price today?

One share of Kura Oncology stock can currently be purchased for approximately $12.00.


MarketBeat Community Rating for Kura Oncology (NASDAQ KURO)
Community Ranking:  3.2 out of 5 (  )
Outperform Votes:  13 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  20
MarketBeat's community ratings are surveys of what our community members think about Kura Oncology and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Kura Oncology (NASDAQ:KURO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Kura Oncology (NASDAQ:KURO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
12/30/2015Oppenheimer Holdings, Inc.Initiated CoverageOutperformN/AView Rating Details
9/17/2015Leerink SwannInitiated CoverageOutperformN/AView Rating Details
(Data available from 7/25/2015 forward)

Earnings

Earnings History for Kura Oncology (NASDAQ:KURO)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Kura Oncology (NASDAQ:KURO)
Current Year EPS Consensus Estimate: $-2.58 EPS
Next Year EPS Consensus Estimate: $-2.50 EPS

Dividends

Dividend History for Kura Oncology (NASDAQ:KURO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Kura Oncology (NASDAQ:KURO)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Kura Oncology (NASDAQ:KURO)
Latest Headlines for Kura Oncology (NASDAQ:KURO)
Source:

Social

Chart

Kura Oncology (KURO) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by MarketBeat.com Staff